Daniel Heudobler

9PUBLICATIONS
51CO-AUTHORS
Tumour immunologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 31, 2026
MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial.

|Feb 26, 2026
Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study.

Mariano Ponz-Sarvisé, Sun Young Rha, Carlos A Gomez-Roca

|Jan 28, 2026
Genome Agnostic Reprogramming of Acute Myelocytic Leukemia Hallmarks by Targeting Non-Oncogene Addictions with Azacitidine Plus Pioglitazone and All-Trans Retinoic Acid.

Dennis Christoph Harrer, Florian Lüke, Tobias Pukrop

|Jan 11, 2024
Addressing Genetic Tumor Heterogeneity, Post-Therapy Metastatic Spread, Cancer Repopulation, and Development of Acquired Tumor Cell Resistance.

Dennis Christoph Harrer, Florian Lüke, Tobias Pukrop

|Oct 23, 2023
CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial.

Andreas Mackensen, John B A G Haanen, Christian Koenecke

|Oct 27, 2022
Identification of Disparities in Personalized Cancer Care-A Joint Approach of the German WERA Consortium.

Florian Lüke, Florian Haller, Kirsten Utpatel

Pageof 2

Frequent Collaborators

4 joint publications

Florian Lüke

3 joint publications

Tobias Pukrop

2 joint publications

Manuel Ruh

2 joint publications

Farastuk Bozorgmehr